Is a complete MEDS research report available?

No complete published report is available for DataMEDS AI, Inc. (MEDS) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

DataMEDS AI, Inc. (MEDS)

NASDAQ: MEDS · USD

$3.17

-0.11 (-3.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first MEDS analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	8M
Revenue (ttm)	14M
Net income (ttm)	-76.6M
EPS (ttm)	-$45.5
Shares out	2.5M
Volume	22,636
Beta	2.17

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 14M
Net income (ttm): -76.6M
EPS (ttm): -$45.5
Market cap: 8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All MEDS indicators

Market & fundamental data

Available fields

167

Groups with data

Currency

USD

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001382574
Company name	DataMEDS AI, Inc.
Country	United States
Country code	US
Cusip	89846A405
Enterprise value	$36.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-07-23
Industry	Pharmaceutical Retailers
IPO Date	2025-02-21
Isin	US89846A4058
Last refreshed	2026-07-27
Market cap	$8M
Market cap category	Nano-Cap
Price	$3.17
Price currency	USD
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Symbol	MEDS
Website	https://datamedsai.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-962.76%
EV/Sales	2.61x
P/S ratio	0.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-49.51%
Gross Profit	$-6.9M
Gross Profit Growth Q	-75.42%
Net Income	$-76.6M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-545.72%
ROA	-79.18
ROCE	2,697.1
ROIC	-159.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-94.03%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-51.59x
Revenue Growth Q	-85.64x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.32
Assets	$30.1M
Cash	$51,730
Current Assets	$2.8M
Current Liabilities	$32.2M
Debt	$28.7M
Equity	$-15.1M
Interest Coverage	-10.05
Liabilities	$45.2M
Long Term Assets	$27.4M
Long Term Liabilities	$13M
Net Cash	$-28.7M
Net Cash By Market Cap	$-361
Tangible Book Value	$-41.3M
Tangible Book Value Per Share	$-17.32
WACC	15.48

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.09
Inventory Turnover	3.67
Net Working Capital	$-13.7M
Quick ratio	0.03
Working Capital	$-29.4M
Working Capital Turnover	$-0.47

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-71.58%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-94.02%
200-day SMA	14.59
50-day SMA	3.75
50-day SMA vs 200-day SMA	50under200
All Time High	352
All Time High Change	-99.1%
All Time High Date	2025-05-08
All Time Low	2.49
All Time Low Change	27.57%
All Time Low Date	2026-07-16
ATR	0.43
Beta	2.17
Beta1y	3.27
Beta2y	0.78
Ch YTD	-84.13
High	3.31
High52	97.5
High52 Date	2025-08-26
High52ch	-96.75%
Low	3.05
Low52	2.49
Low52 Date	2026-07-16
Low52ch	27.57%
Ma50ch	-15.42%
Premarket Change Percent	6.1
Premarket Price	$3.48
Premarket Volume	158
Price vs 200-day SMA	-78.27%
RSI	48.35
RSI Monthly	30.36
RSI Weekly	33.31
Sharpe ratio	-0.22x
Sortino ratio	-0.52
Total Return	-71.58%
Tr YTD	-84.13
Tr1m	1.6%
Tr1w	19.62%
Tr3m	-53.28%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-55.9M
Operating margin	-398

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	614,460%
Float Percent	24.49%
Net Borrowing	810,892
Shares Insiders	59.12%
Shares Institutions	3.74%
Shares Out	2,509,425
Shares Qo Q	8.34%
Shares Yo Y	71.58%
Short Float	2.44%
Short Ratio	0.28
Short Shares	0.6

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	49,192.6x
Bv Per Share	-6.32
Ch1m	1.6
Ch1w	19.62
Ch1y	-94.02
Ch3m	-53.28
Ch6m	-84.22
Change	-3.35%
Change From Open	-2.31
Close	3.28
Days Gap	-1.07
Depreciation Amortization	2,765,017
Dollar Volume	71,756.1
Earnings Date	2026-08-18
EBIT	$-55.9M
EBITDA	$-53.1M
EPS	$-45.5
F Score	1
Financing CF	11,269,345
Fiscal Year End	December
Founded	2,022
Goodwill	14,193,923
Investing CF	-813,491
Iprfo	-98.54
Is Primary Listing	1
Is Spac	No
Last Report Date	2026-03-31
Last Split Date	2026-05-26
Last Split Type	Reverse
Ma150	9.4
Ma150ch	-66.29%
Ma20	3.02
Ma20ch	4.97%
Net CF	-2,464,855
Next Earnings Date	2026-08-18
Open	3.25
Position In Range	46.15
Post Close	3.17
Postmarket Change Percent	4.73
Postmarket Price	$3.32
Ppne	1,045,914
Pre Close	3.28
Price Date	2026-07-24
Relative Volume	0.46x
Revenue	14,033,980x
SBC By Revenue	202.22x
Share Based Comp	28,378,868
Tr6m	-84.22%
Us State	Florida
Volume	22,636
Z Score	-11.32

DataMEDS AI, Inc. (MEDS)

Coverage state: Market snapshot only — no published research

Generate the first MEDS analysis

Price

Financial snapshot

Fair-value bridge

Latest news · MEDS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MEDS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on MEDS

Frequently asked questions